TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
KYMR

Kymera Therapeutics Inc

Healthcare · Biotechnology

115.50$ -5.4% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Kymera Therapeutics Inc (KYMR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 1,743 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet KYMR
Line item 2018 2019 2020 2021 2022 2023 2024 2025
44 117 487 606 603 576 978 1,743
42 93 302 451 419 405 510 871
41 76 31 48 68 110 120 357
41 92 296 442 407 375 489 848
0.1 0.3 1.4 0.1 2.5 19 0.9
-163 -9.0 -12 0.0
2.2 22 21 12 13
79 191 203 146 113 181 142 163
4.7 35 111 93 71 86 68 83
0.3 3.4 3.3 3.6 3.9 6.3 13 14
2.1 3.3 4.4 4.0 4.3 7.1 6.0 4.0
-34 -74 284 460 490 395 836 1,580
-35 -76 -129 -229 -384 -531 -755 -1,066
45 45 45 48 54 58 75 84

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?